- Stock pops pre‑market: BBAI traded around $6.81 (+~19%) before the open after Monday’s results and M&A news.
- Q3 2025 at a glance: Revenue $33.1M (‑20% y/y); gross margin 22.4%; GAAP net income $2.5M (driven largely by non‑cash derivative revaluation); Adjusted EBITDA –$9.4M; backlog $376M.
- Cash & outlook:Record cash $456.6M; FY25 revenue guide reaffirmed at $125M–$140M.
- Deal news: BigBear.ai signed a definitive agreement to acquire Ask Sage for $250M; closing targeted late Q4 2025 or early Q1 2026. Ask Sage projects ~$25M 2025 ARR (non‑GAAP).
- Analyst move today:Cantor Fitzgerald raised its BBAI price target to $7 while keeping a positive stance.
Market reaction: Why BBAI is spiking this morning
BigBear.ai’s pre‑market surge follows a one‑two punch of better‑than‑expected top‑line and a transformational acquisition announced after Monday’s close. Barron’s flagged BBAI among today’s biggest pre‑market movers on the back of the Ask Sage deal and a revenue beat.
Q3 2025 by the numbers
Management highlighted mixed operating trends: a leaner quarter against tough comps and delayed government program volume, but a stronger balance sheet and robust pipeline.
- Revenue:$33.1M (vs. $41.5M a year ago; –20% y/y), primarily on lower volume in certain U.S. Army programs.
- Gross margin:22.4% (25.9% a year ago).
- GAAP net income:$2.5M (vs. –$15.1M), largely driven by non‑cash changes in derivative liabilities tied to 2029 notes and warrants.
- Adjusted EBITDA:–$9.4M (vs. +$0.9M), reflecting lower margin and higher SG&A.
- Backlog:$376M as of Sept. 30, 2025.
- Cash:$456.6M (record balance) positioning the company for M&A and growth investments.
- FY25 outlook:Revenue $125M–$140M, unchanged; management does not expect Ask Sage to materially impact 2025 consolidated results given the closing timeline.
The Ask Sage acquisition: what’s in the deal — and why it matters
BigBear.ai signed a definitive agreement to acquire Ask Sage, a fast‑growing Generative AI platform focused on secure distribution of models and agentic AI in defense, national security, and other highly regulated sectors.
Strategic highlights
- Purchase price:$250M total, structured as $140M in cash plus $110M in either additional cash or BigBear.ai common stock (at BBAI’s option), subject to customary adjustments.
- Consideration mechanics (if stock elected): the number of shares issued depends on a 20‑day VWAP collar with defined share counts above/below thresholds.
- Scale & traction: Ask Sage supports 100,000+ users across 16,000 government teams and hundreds of commercial organizations; it is in production at scale in sensitive environments.
- Financial contribution: Ask Sage is projected to deliver ~$25M in 2025 ARR (non‑GAAP).
- Timing: Closing late Q4 2025 or early Q1 2026, pending approvals (including HSR) and other customary conditions.
CEO Kevin McAleenan framed the combination as creating a secure, integrated AI platform that unifies software, data, and mission services—tailored for defense and other regulated sectors. Management also pointed to potential acceleration in U.S. government tech spending next year.
Street reaction on Nov. 11
Before the bell, Cantor Fitzgerald lifted its BBAI price target to $7, citing the enhanced positioning in secure GenAI and regulated markets post‑deal. That note arrived alongside the pre‑market rally.
What to watch next
- Regulatory & shareholder milestones for Ask Sage (HSR expiration/termination; Ask Sage stockholder approval) and closing timeline into late Q4 or early Q1.
- Program ramps & awards in defense, border security, and international markets as the FY26 budget cycle approaches.
- Margin path back toward breakeven on Adjusted EBITDA as integration proceeds and SG&A normalizes.
Context: a volatile 2025, but a stronger balance sheet now
BigBear.ai shares have seesawed this year amid restatement issues and guidance resets earlier in 2025, which pressured sentiment. The company now emphasizes record liquidity and a targeted M&A strategy to consolidate its niche in secure AI.
Key takeaways for investors
- Catalyst today: A credible M&A target with live federal adoption, coupled with reaffirmed guidance and a sizable cash cushion.
- Execution risk: Integration, timing of federal awards, and the cost to scale commercial go‑to‑market remain the swing factors.
- Valuation watch: With pre‑market levels implying a sharp re‑rating, track whether analyst estimate revisions (post‑deal) keep pace with price.
This article is for informational purposes only and does not constitute investment advice.
